Genomic Approaches to Dissect Human Host-pathogen Interactions in the Amazonian Rainforest
NCT05981378 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-04-24
Summary
This observational study, aims to characterize with a multi-omic approach, the impact of host genetics and the pathogenic environment on immune response variation in Native Amazonians in comparison with Mestizo Amazonian, a severely underrepresented population in genomic studies.
Various samples will be taken from the participants, including blood, urine, saliva, etc. From the blood sample, peripheral blood mononuclear cells will be obtained and will give us information about the differences between immune response variation of Amazonian population. From the other samples we will be able to obtain additional information on the risk factors related to the difference in the immune response of the participants.
Conditions
- Host-Pathogen Interactions
Sponsors & Collaborators
-
Institut Pasteur
collaborator INDUSTRY -
Universidad Peruana Cayetano Heredia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-02
- Primary Completion
- 2024-11-20
- Completion
- 2025-01-30
More Related Trials
-
A Systems Biology Approach to Malaria Immunity
NCT03014258 ·Status: COMPLETED ·Phase: PHASE1
-
Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
NCT01218893 ·Status: COMPLETED ·Phase: NA
-
A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults
NCT03110757 ·Status: COMPLETED ·Phase: PHASE1
-
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
NCT02530697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults
NCT01624961 ·Status: COMPLETED ·Phase: PHASE1
-
Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
NCT02687971 ·Status: COMPLETED ·Phase: PHASE2
-
Exposure of Naive and Pre-immune Subjects to P. Vivax Challenge
NCT01585077 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults
NCT01771848 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.
NCT06000514 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil
NCT05630313 ·Status: UNKNOWN
-
Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis
NCT01422954 ·Status: COMPLETED ·Phase: NA
-
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
NCT00537953 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness of Vaccination Against COVID-19 in Brazil: Case-Control Study
NCT05621928 ·Status: ACTIVE_NOT_RECRUITING
-
First-in-Human PfSPZ-LARC2 Vaccination/CHMI
NCT06735209 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria
NCT03503058 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection
NCT02098590 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
NCT02859350 ·Status: COMPLETED ·Phase: PHASE1
-
Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
NCT05332093 ·Status: COMPLETED
-
Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)
NCT06293339 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
NCT04612972 ·Status: COMPLETED ·Phase: PHASE3
-
Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites
NCT01082341 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)
NCT01032382 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
NCT01790659 ·Status: COMPLETED ·Phase: PHASE3
-
Plasmodium Falciparum Genomic Intelligence in Mozambique
NCT05306067 ·Status: COMPLETED
-
Expression of Mif Alleles in Individuals With Leishmaniasis
NCT00401349 ·Status: COMPLETED